nodes	percent_of_prediction	percent_of_DWPC	metapath
Atazanavir—CYP2C9—urine—polycystic ovary syndrome	0.0303	0.136	CbGeAlD
Atazanavir—Toothache—Metformin—polycystic ovary syndrome	0.0267	0.0563	CcSEcCtD
Atazanavir—Nail disorder—Metformin—polycystic ovary syndrome	0.0251	0.0528	CcSEcCtD
Atazanavir—Saquinavir—CYP11A1—polycystic ovary syndrome	0.0231	1	CrCbGaD
Atazanavir—CYP3A4—urine—polycystic ovary syndrome	0.0231	0.103	CbGeAlD
Atazanavir—SLCO1B3—pituitary gland—polycystic ovary syndrome	0.0222	0.0993	CbGeAlD
Atazanavir—Rhinorrhoea—Metformin—polycystic ovary syndrome	0.0201	0.0423	CcSEcCtD
Atazanavir—SLCO1B3—vagina—polycystic ovary syndrome	0.0184	0.0822	CbGeAlD
Atazanavir—SLCO1B3—endocrine gland—polycystic ovary syndrome	0.0172	0.0769	CbGeAlD
Atazanavir—Nasal congestion—Metformin—polycystic ovary syndrome	0.013	0.0273	CcSEcCtD
Atazanavir—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.0121	0.0255	CcSEcCtD
Atazanavir—Pain in extremity—Metformin—polycystic ovary syndrome	0.0118	0.0249	CcSEcCtD
Atazanavir—Dehydration—Metformin—polycystic ovary syndrome	0.011	0.0231	CcSEcCtD
Atazanavir—Breast disorder—Metformin—polycystic ovary syndrome	0.0107	0.0225	CcSEcCtD
Atazanavir—ABCC1—adrenal cortex—polycystic ovary syndrome	0.0106	0.0475	CbGeAlD
Atazanavir—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.0106	0.0222	CcSEcCtD
Atazanavir—Abdominal distension—Metformin—polycystic ovary syndrome	0.0103	0.0216	CcSEcCtD
Atazanavir—Pancreatitis—Metformin—polycystic ovary syndrome	0.01	0.0211	CcSEcCtD
Atazanavir—Neutropenia—Metformin—polycystic ovary syndrome	0.00955	0.0201	CcSEcCtD
Atazanavir—ABCC1—endometrium—polycystic ovary syndrome	0.00947	0.0424	CbGeAlD
Atazanavir—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00892	0.0188	CcSEcCtD
Atazanavir—ABCC1—uterus—polycystic ovary syndrome	0.00873	0.0391	CbGeAlD
Atazanavir—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00861	0.0181	CcSEcCtD
Atazanavir—ABCC1—pituitary gland—polycystic ovary syndrome	0.00857	0.0384	CbGeAlD
Atazanavir—ABCC1—adipose tissue—polycystic ovary syndrome	0.00853	0.0382	CbGeAlD
Atazanavir—Hepatitis—Metformin—polycystic ovary syndrome	0.00817	0.0172	CcSEcCtD
Atazanavir—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00813	0.0171	CcSEcCtD
Atazanavir—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00805	0.017	CcSEcCtD
Atazanavir—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00803	0.0169	CcSEcCtD
Atazanavir—ABCC1—adrenal gland—polycystic ovary syndrome	0.00766	0.0343	CbGeAlD
Atazanavir—Eye disorder—Metformin—polycystic ovary syndrome	0.00764	0.0161	CcSEcCtD
Atazanavir—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00758	0.016	CcSEcCtD
Atazanavir—Angiopathy—Metformin—polycystic ovary syndrome	0.00741	0.0156	CcSEcCtD
Atazanavir—Immune system disorder—Metformin—polycystic ovary syndrome	0.00738	0.0155	CcSEcCtD
Atazanavir—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00736	0.0155	CcSEcCtD
Atazanavir—ABCC1—female gonad—polycystic ovary syndrome	0.00714	0.032	CbGeAlD
Atazanavir—Malnutrition—Metformin—polycystic ovary syndrome	0.00711	0.015	CcSEcCtD
Atazanavir—ABCC1—vagina—polycystic ovary syndrome	0.00709	0.0318	CbGeAlD
Atazanavir—Flatulence—Metformin—polycystic ovary syndrome	0.00701	0.0148	CcSEcCtD
Atazanavir—Dysgeusia—Metformin—polycystic ovary syndrome	0.00697	0.0147	CcSEcCtD
Atazanavir—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.0066	0.0139	CcSEcCtD
Atazanavir—Malaise—Metformin—polycystic ovary syndrome	0.00642	0.0135	CcSEcCtD
Atazanavir—Syncope—Metformin—polycystic ovary syndrome	0.00638	0.0134	CcSEcCtD
Atazanavir—Palpitations—Metformin—polycystic ovary syndrome	0.00629	0.0132	CcSEcCtD
Atazanavir—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00625	0.0132	CcSEcCtD
Atazanavir—Hypertension—Metformin—polycystic ovary syndrome	0.00614	0.0129	CcSEcCtD
Atazanavir—Myalgia—Metformin—polycystic ovary syndrome	0.00606	0.0128	CcSEcCtD
Atazanavir—Chest pain—Metformin—polycystic ovary syndrome	0.00606	0.0128	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00601	0.0127	CcSEcCtD
Atazanavir—Discomfort—Metformin—polycystic ovary syndrome	0.00598	0.0126	CcSEcCtD
Atazanavir—Oedema—Metformin—polycystic ovary syndrome	0.00581	0.0122	CcSEcCtD
Atazanavir—Infection—Metformin—polycystic ovary syndrome	0.00577	0.0121	CcSEcCtD
Atazanavir—Shock—Metformin—polycystic ovary syndrome	0.00571	0.012	CcSEcCtD
Atazanavir—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00569	0.012	CcSEcCtD
Atazanavir—Skin disorder—Metformin—polycystic ovary syndrome	0.00564	0.0119	CcSEcCtD
Atazanavir—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00561	0.0118	CcSEcCtD
Atazanavir—Anorexia—Metformin—polycystic ovary syndrome	0.00553	0.0117	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00529	0.0111	CcSEcCtD
Atazanavir—ABCB1—embryo—polycystic ovary syndrome	0.00528	0.0237	CbGeAlD
Atazanavir—Dyspnoea—Metformin—polycystic ovary syndrome	0.00518	0.0109	CcSEcCtD
Atazanavir—Somnolence—Metformin—polycystic ovary syndrome	0.00516	0.0109	CcSEcCtD
Atazanavir—Dyspepsia—Metformin—polycystic ovary syndrome	0.00511	0.0108	CcSEcCtD
Atazanavir—Decreased appetite—Metformin—polycystic ovary syndrome	0.00505	0.0106	CcSEcCtD
Atazanavir—CYP2C9—endocrine gland—polycystic ovary syndrome	0.00502	0.0225	CbGeAlD
Atazanavir—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00501	0.0106	CcSEcCtD
Atazanavir—Fatigue—Metformin—polycystic ovary syndrome	0.00501	0.0105	CcSEcCtD
Atazanavir—Constipation—Metformin—polycystic ovary syndrome	0.00496	0.0105	CcSEcCtD
Atazanavir—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00478	0.0101	CcSEcCtD
Atazanavir—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00475	0.01	CcSEcCtD
Atazanavir—Urticaria—Metformin—polycystic ovary syndrome	0.00461	0.00971	CcSEcCtD
Atazanavir—Abdominal pain—Metformin—polycystic ovary syndrome	0.00459	0.00967	CcSEcCtD
Atazanavir—ABCB1—adrenal cortex—polycystic ovary syndrome	0.00433	0.0194	CbGeAlD
Atazanavir—Asthenia—Metformin—polycystic ovary syndrome	0.00417	0.00877	CcSEcCtD
Atazanavir—Pruritus—Metformin—polycystic ovary syndrome	0.00411	0.00865	CcSEcCtD
Atazanavir—Diarrhoea—Metformin—polycystic ovary syndrome	0.00397	0.00837	CcSEcCtD
Atazanavir—ABCB1—endometrium—polycystic ovary syndrome	0.00387	0.0173	CbGeAlD
Atazanavir—Dizziness—Metformin—polycystic ovary syndrome	0.00384	0.00808	CcSEcCtD
Atazanavir—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00383	0.0171	CbGeAlD
Atazanavir—Vomiting—Metformin—polycystic ovary syndrome	0.00369	0.00777	CcSEcCtD
Atazanavir—Rash—Metformin—polycystic ovary syndrome	0.00366	0.00771	CcSEcCtD
Atazanavir—Dermatitis—Metformin—polycystic ovary syndrome	0.00366	0.0077	CcSEcCtD
Atazanavir—Headache—Metformin—polycystic ovary syndrome	0.00364	0.00766	CcSEcCtD
Atazanavir—ABCB1—uterus—polycystic ovary syndrome	0.00356	0.0159	CbGeAlD
Atazanavir—ABCB1—pituitary gland—polycystic ovary syndrome	0.0035	0.0157	CbGeAlD
Atazanavir—ABCB1—adipose tissue—polycystic ovary syndrome	0.00348	0.0156	CbGeAlD
Atazanavir—Nausea—Metformin—polycystic ovary syndrome	0.00345	0.00726	CcSEcCtD
Atazanavir—ABCB1—adrenal gland—polycystic ovary syndrome	0.00313	0.014	CbGeAlD
Atazanavir—ABCB1—female gonad—polycystic ovary syndrome	0.00291	0.013	CbGeAlD
Atazanavir—ABCB1—vagina—polycystic ovary syndrome	0.0029	0.013	CbGeAlD
Atazanavir—ABCB1—endocrine gland—polycystic ovary syndrome	0.00271	0.0121	CbGeAlD
Atazanavir—SLCO1B3—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000577	0.00207	CbGpPWpGaD
Atazanavir—CYP2C9—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000572	0.00205	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000566	0.00203	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—SRD5A1—polycystic ovary syndrome	0.000553	0.00199	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000553	0.00198	CbGpPWpGaD
Atazanavir—CYP2C9—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.00054	0.00194	CbGpPWpGaD
Atazanavir—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—polycystic ovary syndrome	0.00054	0.00194	CbGpPWpGaD
Atazanavir—CYP2C9—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000539	0.00194	CbGpPWpGaD
Atazanavir—CYP2C9—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000532	0.00191	CbGpPWpGaD
Atazanavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00053	0.0019	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000528	0.0019	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—STAR—polycystic ovary syndrome	0.000528	0.00189	CbGpPWpGaD
Atazanavir—SLCO1B3—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000528	0.00189	CbGpPWpGaD
Atazanavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000527	0.00189	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.000526	0.00189	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000522	0.00187	CbGpPWpGaD
Atazanavir—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.00052	0.00187	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000501	0.0018	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.0005	0.00179	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000492	0.00177	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—TEAD2—polycystic ovary syndrome	0.000492	0.00177	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000491	0.00176	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000491	0.00176	CbGpPWpGaD
Atazanavir—CYP2C9—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000483	0.00173	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000473	0.0017	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—HMMR—polycystic ovary syndrome	0.00047	0.00169	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000466	0.00167	CbGpPWpGaD
Atazanavir—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000463	0.00166	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—HSD3B1—polycystic ovary syndrome	0.000449	0.00161	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000444	0.00159	CbGpPWpGaD
Atazanavir—SLCO1B3—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000443	0.00159	CbGpPWpGaD
Atazanavir—ABCC1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000439	0.00157	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000432	0.00155	CbGpPWpGaD
Atazanavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000427	0.00153	CbGpPWpGaD
Atazanavir—CYP2C9—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000427	0.00153	CbGpPWpGaD
Atazanavir—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000426	0.00153	CbGpPWpGaD
Atazanavir—CYP2C9—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000421	0.00151	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.00042	0.00151	CbGpPWpGaD
Atazanavir—ABCC1—Disease—RPL37A—polycystic ovary syndrome	0.000419	0.0015	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000413	0.00148	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000412	0.00148	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—LHB—polycystic ovary syndrome	0.000409	0.00147	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.000409	0.00147	CbGpPWpGaD
Atazanavir—ABCC1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000408	0.00146	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—HSD3B2—polycystic ovary syndrome	0.0004	0.00144	CbGpPWpGaD
Atazanavir—ABCC1—Disease—HMMR—polycystic ovary syndrome	0.000397	0.00143	CbGpPWpGaD
Atazanavir—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000393	0.00141	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000391	0.0014	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.00039	0.0014	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—AKR1C1—polycystic ovary syndrome	0.000387	0.00139	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000383	0.00137	CbGpPWpGaD
Atazanavir—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000377	0.00135	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—STAR—polycystic ovary syndrome	0.000373	0.00134	CbGpPWpGaD
Atazanavir—ABCC1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000373	0.00134	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000372	0.00134	CbGpPWpGaD
Atazanavir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—polycystic ovary syndrome	0.000371	0.00133	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000369	0.00132	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—SULT2A1—polycystic ovary syndrome	0.000356	0.00128	CbGpPWpGaD
Atazanavir—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000356	0.00128	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000356	0.00128	CbGpPWpGaD
Atazanavir—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000351	0.00126	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000348	0.00125	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—RRM2—polycystic ovary syndrome	0.000345	0.00124	CbGpPWpGaD
Atazanavir—CYP2C9—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000344	0.00123	CbGpPWpGaD
Atazanavir—CYP2C9—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000339	0.00122	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—YAP1—polycystic ovary syndrome	0.000333	0.00119	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—HMMR—polycystic ovary syndrome	0.000333	0.00119	CbGpPWpGaD
Atazanavir—ABCC1—Disease—AKR1C1—polycystic ovary syndrome	0.000327	0.00117	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—NMNAT3—polycystic ovary syndrome	0.000324	0.00116	CbGpPWpGaD
Atazanavir—ABCB1—Allograft Rejection—VEGFA—polycystic ovary syndrome	0.000322	0.00115	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—NAMPT—polycystic ovary syndrome	0.00032	0.00115	CbGpPWpGaD
Atazanavir—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000318	0.00114	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000318	0.00114	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000317	0.00114	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000317	0.00114	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—CYP11A1—polycystic ovary syndrome	0.000316	0.00113	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000314	0.00113	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000314	0.00113	CbGpPWpGaD
Atazanavir—ABCC1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000313	0.00112	CbGpPWpGaD
Atazanavir—ABCC1—Disease—FGF18—polycystic ovary syndrome	0.000303	0.00109	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—NMNAT3—polycystic ovary syndrome	0.000303	0.00109	CbGpPWpGaD
Atazanavir—ABCC1—Disease—RBP4—polycystic ovary syndrome	0.000301	0.00108	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—AKR1C3—polycystic ovary syndrome	0.000298	0.00107	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000297	0.00107	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—LPCAT2—polycystic ovary syndrome	0.000296	0.00106	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—SUOX—polycystic ovary syndrome	0.000296	0.00106	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—CYP17A1—polycystic ovary syndrome	0.000294	0.00105	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—LHB—polycystic ovary syndrome	0.000289	0.00104	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000289	0.00104	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000283	0.00101	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000282	0.00101	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000282	0.00101	CbGpPWpGaD
Atazanavir—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000278	0.000996	CbGpPWpGaD
Atazanavir—ABCC1—Disease—GAB1—polycystic ovary syndrome	0.000277	0.000995	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—LPCAT2—polycystic ovary syndrome	0.000277	0.000993	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—SUOX—polycystic ovary syndrome	0.000277	0.000993	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ISYNA1—polycystic ovary syndrome	0.000275	0.000989	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000274	0.000983	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000273	0.000981	CbGpPWpGaD
Atazanavir—ABCC1—Disease—NAMPT—polycystic ovary syndrome	0.00027	0.000969	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ISYNA1—polycystic ovary syndrome	0.000257	0.000924	CbGpPWpGaD
Atazanavir—CYP2C9—Biological oxidations—POMC—polycystic ovary syndrome	0.000257	0.000921	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—TH—polycystic ovary syndrome	0.000254	0.000912	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000252	0.000905	CbGpPWpGaD
Atazanavir—ABCC1—Disease—AKR1C3—polycystic ovary syndrome	0.000252	0.000904	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000252	0.000903	CbGpPWpGaD
Atazanavir—ABCC1—Disease—TNRC6B—polycystic ovary syndrome	0.000248	0.000889	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—SLC2A4—polycystic ovary syndrome	0.000247	0.000887	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—RRM2—polycystic ovary syndrome	0.000244	0.000876	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.000243	0.000872	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—YAP1—polycystic ovary syndrome	0.000235	0.000844	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000235	0.000843	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000234	0.000841	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—TEAD2—polycystic ovary syndrome	0.000234	0.000841	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—CYP19A1—polycystic ovary syndrome	0.000232	0.000834	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000227	0.000814	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—NAMPT—polycystic ovary syndrome	0.000226	0.000811	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000225	0.000807	CbGpPWpGaD
Atazanavir—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000224	0.000803	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000223	0.000801	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000223	0.0008	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000222	0.000795	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	0.000219	0.000785	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	0.000219	0.000785	CbGpPWpGaD
Atazanavir—ABCC1—Disease—TCF7L2—polycystic ovary syndrome	0.000212	0.000762	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000212	0.000761	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000211	0.000757	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.00021	0.000755	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000209	0.000749	CbGpPWpGaD
Atazanavir—ABCC1—Disease—SLC2A4—polycystic ovary syndrome	0.000209	0.000749	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000208	0.000745	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—GNAS—polycystic ovary syndrome	0.000207	0.000744	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000207	0.000743	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.0002	0.000716	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PRL—polycystic ovary syndrome	0.000199	0.000714	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—NCOR1—polycystic ovary syndrome	0.000198	0.000709	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000196	0.000704	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000194	0.000696	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—CYP1A1—polycystic ovary syndrome	0.000187	0.000672	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000186	0.000668	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	0.000183	0.000658	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000183	0.000655	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000183	0.000655	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—TH—polycystic ovary syndrome	0.00018	0.000645	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—STAR—polycystic ovary syndrome	0.000178	0.000637	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000177	0.000637	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000175	0.000627	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—MTHFR—polycystic ovary syndrome	0.000175	0.000627	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	0.000174	0.000624	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.00017	0.000609	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000169	0.000607	CbGpPWpGaD
Atazanavir—ABCC1—Disease—NCOR1—polycystic ovary syndrome	0.000167	0.000599	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	0.000166	0.000595	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CYP19A1—polycystic ovary syndrome	0.000164	0.000589	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000164	0.000588	CbGpPWpGaD
Atazanavir—ABCC1—Disease—NRG1—polycystic ovary syndrome	0.000164	0.000587	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000159	0.000569	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	0.000158	0.000568	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000151	0.000542	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000149	0.000534	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	0.000148	0.00053	CbGpPWpGaD
Atazanavir—ABCC1—Disease—MTHFR—polycystic ovary syndrome	0.000147	0.000529	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—GNAS—polycystic ovary syndrome	0.000147	0.000526	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000144	0.000518	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000144	0.000518	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PPARG—polycystic ovary syndrome	0.000142	0.000508	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	0.000141	0.000506	CbGpPWpGaD
Atazanavir—ABCC1—Disease—IRS2—polycystic ovary syndrome	0.00014	0.000503	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—NCOR1—polycystic ovary syndrome	0.00014	0.000501	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—POMC—polycystic ovary syndrome	0.00014	0.000501	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000139	0.0005	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—INS—polycystic ovary syndrome	0.000139	0.000498	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—LHB—polycystic ovary syndrome	0.000138	0.000494	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000135	0.000483	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CYP1A1—polycystic ovary syndrome	0.000132	0.000475	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000132	0.000474	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	0.00013	0.000468	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	0.000129	0.000461	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	0.000126	0.000451	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—MTHFR—polycystic ovary syndrome	0.000123	0.000443	CbGpPWpGaD
Atazanavir—ABCC1—Disease—IRS1—polycystic ovary syndrome	0.000122	0.000439	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	0.000122	0.000437	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.000121	0.000434	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	0.00012	0.00043	CbGpPWpGaD
Atazanavir—ABCC1—Disease—INS—polycystic ovary syndrome	0.000117	0.000421	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	0.000116	0.000417	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	0.000115	0.000411	CbGpPWpGaD
Atazanavir—ABCC1—Disease—AKT2—polycystic ovary syndrome	0.000113	0.000407	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	0.000112	0.000402	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	0.000112	0.000402	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	0.000109	0.000393	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	0.000108	0.000389	CbGpPWpGaD
Atazanavir—ABCC1—Disease—SERPINE1—polycystic ovary syndrome	0.000108	0.000386	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	0.000108	0.000386	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000106	0.000381	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	0.000105	0.000375	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	0.0001	0.000361	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	0.0001	0.00036	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PPARG—polycystic ovary syndrome	0.0001	0.000359	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	9.99e-05	0.000358	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	9.92e-05	0.000356	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	9.87e-05	0.000354	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—POMC—polycystic ovary syndrome	9.87e-05	0.000354	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	9.85e-05	0.000354	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—INS—polycystic ovary syndrome	9.82e-05	0.000352	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	9.75e-05	0.00035	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	9.37e-05	0.000336	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	9.3e-05	0.000334	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	9.22e-05	0.000331	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—TH—polycystic ovary syndrome	8.54e-05	0.000307	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	8.48e-05	0.000304	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	8.31e-05	0.000298	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	8.29e-05	0.000297	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	8.03e-05	0.000288	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—TH—polycystic ovary syndrome	7.98e-05	0.000286	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	7.81e-05	0.00028	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	7.76e-05	0.000279	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	7.39e-05	0.000265	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	7.3e-05	0.000262	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	7.15e-05	0.000257	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	6.97e-05	0.00025	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	6.9e-05	0.000248	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	6.64e-05	0.000238	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	6.63e-05	0.000238	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	6.54e-05	0.000235	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	6.52e-05	0.000234	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	6.3e-05	0.000226	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	6.21e-05	0.000223	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	6.18e-05	0.000222	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	6.08e-05	0.000218	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	5.88e-05	0.000211	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	5.87e-05	0.000211	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	5.49e-05	0.000197	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—TH—polycystic ovary syndrome	5.26e-05	0.000189	CbGpPWpGaD
Atazanavir—ABCC1—Disease—IL6—polycystic ovary syndrome	5.12e-05	0.000184	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	5.12e-05	0.000184	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	4.81e-05	0.000173	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	4.76e-05	0.000171	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—POMC—polycystic ovary syndrome	4.7e-05	0.000169	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—INS—polycystic ovary syndrome	4.67e-05	0.000168	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	4.45e-05	0.00016	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	4.39e-05	0.000157	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—INS—polycystic ovary syndrome	4.36e-05	0.000157	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	4.3e-05	0.000154	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	4.09e-05	0.000147	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	3.88e-05	0.000139	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	3.62e-05	0.00013	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	2.93e-05	0.000105	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	2.89e-05	0.000104	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—INS—polycystic ovary syndrome	2.88e-05	0.000103	CbGpPWpGaD
